CTSS and breast cancer: Notably, targeted delivery and increased bioavailability of inhibitor through the use of ferri-liposome nano-carriers resulted in significant cathepsin inhibition in distant organs and led to significant reduction of mammary tumor burden volume that have been confirmed by the alterations in tumor marker expression, as Ki67 and E-cadherin (Mikhaylov et al., 2011).